OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
$1.10−0.06 (-5.56%)
Close on Nov 17, 2026Market cap $57.99MP/E –Yield –
OKYO Pharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for OKYO Pharma
OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?